- Teladoc Health press release (NYSE:TDOC): Q2 GAAP EPS of -$0.40 in-line.
- Revenue of $652.4M (+10.1% Y/Y) beats by $3.22M.
- Access fees revenue grew 11% to $575.7 million and other revenue grew 4% to $76.7 million. U.S. revenue grew 8% to $561.8 million and International revenue grew 28% to $90.6 million.
- Shares +7%.
- Second quarter 2023 adjusted EBITDA of $72.2 million
- 3Q23 Guidance: Revenue: $650M-$675M vs $663.28M consensus. Net loss per share: -$0.40 - -$0.50 vs -$0.36 consensus.
- FY23 Guidance: Revenue: $2.6-2.675B vs $2.62B consensus. Net loss per share: -$1.60 - -$1.25 vs -$1.34 consensus.